US Market for Diabetes Monitoring, Treatment and Drug Delivery 2012 – MedSuite

ReportIcon-Diabetes-MS

US Market for Diabetes Monitoring, Treatment and Drug Delivery 2012 – MedSuite

  • Year: 2012
  • Scope: 2008-2018
  • Region: United States
  • Published Date: 07/01/2012
  • Pages: 270
  • Type: MedSuite

0

This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population. Diabetes mellitus is a disease characterized by hyperglycemia, or an excessive amount of blood glucose. Diabetes results when there are defects in insulin production or usage, or a combination of the two. Insulin is a hormone that allows cells to convert sugar (glucose), starch and other food into energy. It is produced in the beta cells of the pancreas and promotes glucose uptake by cells in the body for energy. Insulin further converts excess sugars to glycogen, which is stored in the liver and muscles. If excess glucose builds up in the blood instead of the cells, cells are starved for energy and high levels of glucose become present in the blood.

    

The U.S. market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17.87 billion by 2018.

The market segments covered in this report include:

• traditional blood glucose meters,
• continuous glucose monitoring systems,
• blood glucose test strips,
• lancets and lancing devices,
• insulin,
• insulin syringes,
• insulin pens and
• insulin pumps

Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Market growth for diabetes diagnosis, treatment and drug delivery will be led by double-digit growth in the continuous glucose monitor, insulin pen and insulin pump segments.

Within the diabetes diagnosis, treatment and drug deliver market, companies such as Novo Nordisk, Sanofi, Eli Lilly and Lifescan lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.



Welcome to the new iData Website!

Visit the report store to browse our titles

BROWSE REPORT CATEGORIES

 

Register to see Pricing, TOCs, Expert Articles and more

SIGN UP FOR FREE

×

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Register

×